Clinical trial
Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using…
NCT00458250 · Tehran University of Medical Sciences, Other · Completed
Key facts
| NCT number | NCT00458250 |
|---|---|
| Title | Feasibility of Haploidentical Hematopoietic Stem Cell Transplantation Using CAMPATH-1H |
| Official title | Haploidentical Hematopoietic Stem Cell Transplantation in the Treatment of Hematological Malignancies Using CAMPATH-1H |
| Lead sponsor | Tehran University of Medical Sciences, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia, Myeloid, Acute, Lymphoblastic |
| Intervention type | Drug, Procedure |
| Interventions | Haploidentical hematopoietic stem cell transplantation, Busulfan, Cyclophosphamide, CAMPATH-1H, Cyclosporin A, Methotrexate |
| Enrollment | 10 |
| Start date | Sep 1, 2006 |
| Completion | Feb 1, 2008 |
| First posted | Apr 10, 2007 |
| Last update posted | Nov 18, 2008 |
| Countries | Iran |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: